DV
Dividend Vision

SXTC — China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals Inc (SXTC)

Its deepest 1-year drawdown was 100.0%.

This equity fund tracks China SXT Pharmaceuticals Inc, a single-stock holding focused on the pharmaceutical sector. With no reported distribution rate or dividend yield profile, this is structured as a growth-oriented equity position rather than an income-generating vehicle. The fund may appeal primarily to investors seeking exposure to Chinese pharmaceutical companies rather than those prioritizing regular dividend income.

SXTC key facts

Asset type
Stock
Asset class
Equity
Inception date
01/04/2019
Last close
$4.33
Market cap
$102,424,456
Average volume
16037900.0
Beta
1.817
Payout ratio
0.0
Forward P/E
0.0
EPS
$-10.07